High IL‐6/IFN‐γ ratio could be associated with severe disease in COVID‐19 patients
High IL‐6/IFN‐γ ratio could be associated with severe disease in COVID‐19 patients is a paper indexed in ScholarIQ from OpenAlex.
How many citations does High IL‐6/IFN‐γ ratio could be associated with severe disease in COVID‐19 patients have?
High IL‐6/IFN‐γ ratio could be associated with severe disease in COVID‐19 patients has 170 citations in the OpenAlex counts ScholarIQ stores.
When was High IL‐6/IFN‐γ ratio could be associated with severe disease in COVID‐19 patients published?
High IL‐6/IFN‐γ ratio could be associated with severe disease in COVID‐19 patients has 2020 year in the ScholarIQ index.
What is the open-access status of High IL‐6/IFN‐γ ratio could be associated with severe disease in COVID‐19 patients?
High IL‐6/IFN‐γ ratio could be associated with severe disease in COVID‐19 patients has bronze oa status in the ScholarIQ index.
What is the DOI of High IL‐6/IFN‐γ ratio could be associated with severe disease in COVID‐19 patients?
The DOI for High IL‐6/IFN‐γ ratio could be associated with severe disease in COVID‐19 patients is on the source record.
What is the PMID of High IL‐6/IFN‐γ ratio could be associated with severe disease in COVID‐19 patients?
The PMID for High IL‐6/IFN‐γ ratio could be associated with severe disease in COVID‐19 patients is on the source record.
What is the OpenAlex record for High IL‐6/IFN‐γ ratio could be associated with severe disease in COVID‐19 patients?
The OpenAlex for High IL‐6/IFN‐γ ratio could be associated with severe disease in COVID‐19 patients is on the source record.